Background The risk of thromboembolic events is higher among cancer patients, especially
in patients undergoing chemotherapy. Cisplatin-based regimens claim to be associated with …

Patients with cancer are at a much higher risk of thromboembolic events. Such events are
occasionally associated with significant complications that can negatively affect patients' …

Background Venous thromboembolic events (VTE) are commonly encountered in patients
with lymphoma. Several risk assessments models (RAM) had attempted to identify higher …

Venous thromboembolism (VTE) is a commonly encountered problem in patients with
cancer. In recent years, cancer treatment paradigm has shifted with most therapy offered in …

Background: Venous thromboembolism (VTE) is a serious threat for cancer patients.
Guidelines recommend low-molecular-weight heparin (LMWH) for prophylaxis and …

Purpose To explore the clinical significance of plasma d-dimer increase for transcatheter
arterial chemoembolization (TACE) in patients with primary liver cancer (PLC). Methods The …

Цель. Выявить наиболее значимые предикторы развития послеоперационных
венозных тромбоэмболических осложнений (ВТЭО) у пациентов из группы высокого …

OBJECTIVES: The VOICE Asia study aimed to establish the mode of thromboprophylaxis in
medical patients admitted to intensive care units (ICU), and to describe the epidemiology of …

В настоящей монографии изложены вопросы этиологии и патогенеза, принципы
оценки риска, а также ключевые подходы к профилактике развития …

Background: A majority of patients included in risk assessment models (RAMs) developed to
predict venous thromboembolic events (VTE) in lymphoma were non-Hodgkin lymphoma …